Fig. 3
From: High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma
Prognostic value of MICAL-L2 expression for clinical outcomes in colon adenocarcinoma (COAD) patients. A&B Kaplan–Meier analysis of overall survival (OS) (A) and disease-specific survival (DSS) (B) in patients with COAD. C–H Kaplan–Meier analysis of subgroup OS in patients with COAD. (C) Age ≤ 65, (D) stages T1 and T2, (E) male, (F) age > 65, (G) stages T3 and T4, and (H) female